Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

25.13
+0.41501.68%
Post-market: 25.130.00000.00%18:35 EDT
Volume:6.86M
Turnover:169.86M
Market Cap:9.72B
PE:-2.71
High:25.34
Open:24.03
Low:23.30
Close:24.72
Loading ...

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Business Wire
·
2 hours ago

Wolfe Research Adjusts Moderna Price Target to $20 From $25, Keeps Underperform Rating

MT Newswires Live
·
Yesterday

Moderna’s Market Challenges: Hold Rating Amid Regulatory Uncertainty and Competitive Pressures

TIPRANKS
·
17 Apr

Leerink Partners Sticks to Their Sell Rating for Moderna (MRNA)

TIPRANKS
·
17 Apr

Bloom Energy, Rogers, 3D Systems, Moderna, and EchoStar Stocks Trade Down, What You Need To Know

StockStory
·
17 Apr

Stock Track | Moderna Plummets 5% as CDC Considers Narrowing COVID Booster Recommendations

Stock Track
·
17 Apr

Stock Track | Moderna Plummets 5.03% as CDC Considers Narrower COVID Booster Recommendations and Analysts Cut Target Price

Stock Track
·
17 Apr

Moderna Shares Down 1.4%, Novavax Shares Down 1% in Early Trading

THOMSON REUTERS
·
16 Apr

Shares of Some Vaccine Makers Fall After US Cdc Advisers Discuss Narrower Use of Covid Booster Shots

THOMSON REUTERS
·
16 Apr

BUZZ-Moderna, Novavax fall as CDC advisers discuss risk-based use of COVID shots

Reuters
·
16 Apr

Shares of Moderna Down 1.2%, Novavax Down 1.3% Premarket

THOMSON REUTERS
·
16 Apr

Moderna : Leerink Partners Cuts Target Price to $23 From $27

THOMSON REUTERS
·
16 Apr

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

Reuters
·
16 Apr

US Begins Probes into Pharmaceutical, Chip Imports, Setting Stage for Tariffs

Reuters
·
15 Apr

Pharmaceutical Stocks Trim Their Gains. Trump Says Pharmaceutical Tariffs in Not Too Distant Future

Tiger Newspress
·
15 Apr

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings

Zacks
·
14 Apr

Jefferies Keeps Their Hold Rating on Moderna (MRNA)

TIPRANKS
·
14 Apr

Goldman Sachs Adjusts Price Target on Moderna to $35 From $49

MT Newswires Live
·
14 Apr

Moderna Inc. Stock Advances 6.9%, Outperforms Competitors

Dow Jones
·
12 Apr

NVAX Stock Tanks as HHS Secretary Raises Concern Over COVID-19 Jab

Zacks
·
11 Apr